Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MEDP | D | Medpace Holdings, Inc. | -1.19 | |
SRPT | D | Sarepta Therapeutics, Inc. | 3.38 | |
MRSN | D | Mersana Therapeutics, Inc. | 3.03 | |
GLPG | D | Galapagos NV | 7.57 | |
ICLR | D | ICON plc | 0.70 | |
AMPE | D | Ampio Pharmaceuticals, Inc. | 0.00 | |
SVRA | D | Savara, Inc. | 3.70 | |
CLDX | F | Celldex Therapeutics, Inc. | 3.05 | |
RCUS | F | Arcus Biosciences, Inc. | 2.94 | |
XTLB | F | XTL Biopharmaceuticals Ltd. | 2.73 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Biopharmaceutical
Central Nervous System Disorders
Nervous System Disorders
Organ Systems
Pain
Autoimmune Disease
Cancer
Depression
Insomnia
Monoclonal Antibodies
Monoclonal Antibody
Oncology
Pulmonology
Rare Diseases
Alcohol
Alzheimer's Disease
Antibodies
Antibody Drug Conjugate
Antidepressants
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PINK | D | Simplify Health Care ETF | 14.21 | |
BBH | D | Market Vectors Biotech ETF | 8.73 | |
IDNA | F | iShares Genomics Immunology and Healthcare ETF | 7.66 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 7.16 | |
IBBQ | F | Invesco Nasdaq Biotechnology ETF | 6.83 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Cancer
Medicine
Monoclonal Antibodies
Biology
Biotechnology
Sarcoma
Antibodies
Bone
Breast Cancer
Clinical Research
Colorectal Cancer
Drugs
Human Monoclonal Antibodies
Immunology
Infectious Diseases
Life Sciences
Macular Degeneration
Treatment Of Breast Cancer
Adenosine
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles